Patents by Inventor Chiyoka Ozaki

Chiyoka Ozaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7414066
    Abstract: The present invention provides to a novel compound having an ACAT inhibiting activity.
    Type: Grant
    Filed: November 9, 2004
    Date of Patent: August 19, 2008
    Assignee: Kowa Company Ltd.
    Inventors: Kimiyuki Shibuya, Toru Miura, Katsumi Kawamine, Yukihiro Sato, Tadaaki Ohgiya, Takahiro Kitamura, Chiyoka Ozaki, Toshiyuki Edano, Mitsuteru Hirata
  • Patent number: 7393866
    Abstract: The present invention provides to a novel compound having an ACAT inhibiting activity.
    Type: Grant
    Filed: November 9, 2004
    Date of Patent: July 1, 2008
    Assignee: Kowa Company, Ltd.
    Inventors: Kimiyuki Shibuya, Toru Miura, Katsumi Kawamine, Yukihiro Sato, Tadaaki Ohgiya, Takahiro Kitamura, Chiyoka Ozaki, Toshiyuki Edano, Mitsuteru Hirata
  • Patent number: 6969711
    Abstract: The present invention offers novel cyclic diamine compounds and a pharmaceutical composition containing the same. The present invention relates to a compound represented by the formula (I) or salt(s) or solvate(s) thereof. (In the formula, is an optionally substituted divalent residue of benzene, pyridine, cyclohexane or naphthalene or is a vinylene group where Ar is an optionally substituted aryl group; X is —NH—, oxygen atom or sulfur atom; Y is —NR1—, oxygen atom, sulfur atom, sulfoxide or sulfone; Z is a single bond or —NR2—; R1 is hydrogen atom, optionally substituted lower alkyl group, optionally substituted aryl group or optionally substituted silyl lower alkyl group; R2 is hydrogen atom, optionally substituted lower alkyl group, optionally substituted aryl group or optionally substituted silyl lower alkyl group; l is an integer of from 0 to 15; m is an integer of 2 or 3; and n is an integer of from 0 to 3).
    Type: Grant
    Filed: February 20, 2003
    Date of Patent: November 29, 2005
    Assignee: Kowa Company, Ltd.
    Inventors: Kimiyuki Shibuya, Katsumi Kawamine, Yukihiro Sato, Toru Miura, Chiyoka Ozaki, Toshiyuki Edano, Mitsuteru Hirata, Tadaaki Ohgiya
  • Publication number: 20050131001
    Abstract: The present invention provides to a novel compound having an ACAT inhibiting activity.
    Type: Application
    Filed: November 9, 2004
    Publication date: June 16, 2005
    Inventors: Kimiyuki Shibuya, Toru Miura, Katsumi Kawamine, Yukihiro Sato, Tadaaki Ohgiya, Takahiro Kitamura, Chiyoka Ozaki, Toshiyuki Edano, Mitsuteru Kirata
  • Publication number: 20050131002
    Abstract: The present invention provides to a novel compound having an ACAT inhibiting activity.
    Type: Application
    Filed: November 9, 2004
    Publication date: June 16, 2005
    Inventors: Kimiyuki Shibuya, Toru Miura, Katsumi Kawamine, Yukihiro Sato, Tadaaki Ohgiya, Takahiro Kitamura, Chiyoka Ozaki, Toshiyuki Edano, Mitsuteru Hirata
  • Patent number: 6849647
    Abstract: The present invention provides to a novel compound having an ACAT inhibiting activity.
    Type: Grant
    Filed: September 20, 2000
    Date of Patent: February 1, 2005
    Assignee: Kowa Company, Ltd.
    Inventors: Kimiyuki Shibuya, Toru Miura, Katsumi Kawamine, Yukihiro Sato, Tadaaki Ohgiya, Takahiro Kitamura, Chiyoka Ozaki, Toshiyuki Edano, Mitsuteru Hirata
  • Patent number: 6797717
    Abstract: The invention relates to a novel anilide compound and a pharmaceutical composition comprising the same. The invention relates to a compound represented by the following general formula: represents a divalent residue of benzene with a substituent(s), heterocycle-condensed benzene which may or may not have a substituent, pyridine which may or may not have a substituent, cyclohexane or naphthalene Ar represents an aryl group which may or may not have a substituent, X represents —NH—, oxygen atom or sulfur atom; Y represents —NR4—, oxygen atom, sulfur atom, sulfoxide or sulfone; Z represents single bond or —NR5—; R4 represents hydrogen atom, a lower alkyl group, an aryl group or a silylated lower alkyl group which may or may not have a substituent; R5 represents hydrogen atom, a lower alkyl group, an aryl group or a silylated lower alkyl group which may or may not have a substituent; and n represents an integer of 0 to 15.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: September 28, 2004
    Assignee: Kowa Company, Ltd.
    Inventors: Kimiyuki Shibuya, Katsumi Kawamine, Yukihiro Sato, Toshiyuki Edano, Mitsuteru Hirata, Chiyoka Ozaki
  • Publication number: 20040038987
    Abstract: The present invention offers novel cyclic diamine compounds and a pharmaceutical composition containing the same.
    Type: Application
    Filed: February 20, 2003
    Publication date: February 26, 2004
    Applicant: Kowa Company, Ltd.
    Inventors: Kimiyuki Shibuya, Katsumi Kawamine, Yukihiro Sato, Toru Miura, Chiyoka Ozaki, Toshiyuki Edano, Mitsuteru Hirata, Tadaaki Ohgiya
  • Publication number: 20030087928
    Abstract: The invention relates to novel anilide compounds represented by the following formula IV: 1
    Type: Application
    Filed: February 20, 2002
    Publication date: May 8, 2003
    Applicant: Kowa Company, Ltd., Japan
    Inventors: Kimiyuki Shibuya, Katsumi Kawamine, Yukihiro Sato, Toshiyuki Edano, Mitsuteru Hirata, Chiyoka Ozaki
  • Publication number: 20020099074
    Abstract: The invention relates to a novel anilide compound and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: December 19, 2001
    Publication date: July 25, 2002
    Applicant: Kowa Company, Ltd.,Japan
    Inventors: Kimiyuki Shibuya, Katsumi Kawamine, Yukihiro Sato, Toshiyuki Edano, Mitsuteru Hirata, Chiyoka Ozaki
  • Patent number: 6362208
    Abstract: The invention relates to a novel anilide compound and a pharmaceutical composition comprising the same. The invention relates to a compound represented by the following general formula: represents a divalent residue of benzene with a substituent(s), heterocycle-condensed benzene which may or may not have a substituent, pyridine which may or may not have a substituent, cyclohexane or naphthalene or Ar represents an aryl group which may or may not have a substituent; X represents —NH—, oxygen atom or sulfur atom; Y represents —NR4—, oxygen atom, sulfur atom, sulfoxide or sulfone; Z represents single bond or —NR5—; R4 represents hydrogen atom, a lower alkyl group, an aryl group or a silylated lower alkyl group which may or may not have a substituent; R5 represents hydrogen atom, a lower alkyl group, an aryl group or a silylated lower alkyl group which may or may not have a substituent; and n represents an integer of 0 to 15.
    Type: Grant
    Filed: December 6, 1999
    Date of Patent: March 26, 2002
    Assignee: Kowa Company, Ltd.
    Inventors: Kimiyuki Shibuya, Katsumi Kawamine, Yukihiro Sato, Toshiyuki Edano, Mitsuteru Hirata, Chiyoka Ozaki